Eufillin Eufillin: instructions for use, indications, price, reviews during pregnancy

Pharmacodynamics and pharmacokinetics

The mechanism of action of aminophylline (in Latin - aminophylline) is associated with its ability to block purine (adenosine) A2-type receptors of bronchial smooth muscle cells, increase the accumulation of cyclic AMP in tissues, suppress PDE, reduce the flow of Ca ions through plasma membrane channels (cell membranes), reduce contractile activity smooth muscle activity.

The effects of the drug manifest themselves as:

relaxation of the bronchial muscles;
stimulation of diaphragm contractions;
increasing mucociliary clearance;
improving the function of intercostal and respiratory muscles;
stimulation of the respiratory center and increasing its sensitivity to CO2;
improving alveolar ventilation.

All this helps to reduce the severity and frequency of episodes of respiratory arrest ( apnea ).

By normalizing breathing, it ensures better oxygen saturation of the blood and helps reduce CO2 concentration. Stimulates the activity of the heart muscle, increases the number and strength of its contractions, improves blood circulation through the blood vessels of the heart and increases the myocardial need for oxygen.

Reduces tension in the vascular walls, promotes dilation of peripheral vessels, reduces vascular resistance in the lungs, and reduces pressure in the pulmonary circulation.

It is a diuretic of moderate strength, increases the volume of blood flow in the kidneys, promotes the dilation of the bile ducts, suppresses platelet aggregation, increases the resistance of red blood cells to deformation (improves blood rheology), normalizes microcirculation and reduces thrombus formation.

Reduces the excitability and contractility of the myometrium (tocolytic effect), in high doses it has an epileptogenic effect .

Absorption from the gastrointestinal tract when taken orally is rapid. Food does not change its magnitude, but reduces its speed. The degree of absorption also depends on the dose: the higher it is, the slower aminophylline .

In a healthy adult, about 60% of the dose of aminophylline is bound to plasma proteins, in a patient with liver cirrhosis - about 35%, in infants during the newborn period - 36%.

TSmax for regular tablets is 60-120 minutes.

In the liver, part of the administered dose of aminophylline is biotransformed into caffeine . T1/2 of caffeine in children under 3 years of age is longer than in adults. The concentration of the substance in a child can reach 30% of the concentration of aminophylline .

In patients older than three years of age, the phenomenon of caffeine is not observed.

The T1/2 indicator is influenced by concomitant diseases and the patient’s age. In children under six months of age, as well as in adult patients with heart failure , COPD and cor pulmonale, it is more than 24 hours, in children over six months of age - 3.7, in non-asthmatic adults - 8.7, in people who smoke more than 20 cigarettes a day - 4-5 hours. After quitting smoking, it takes at least 3 months for the pharmacokinetics of the drug to normalize.

Eliminated by the kidneys, about 10% is excreted in pure form in adults, and about half of the taken dose of aminophylline is excreted in children.

Contraindications

Eufillin is not a completely safe drug and has a fairly wide list of contraindications for its use:

Individual hypersensitivity to one or more components of the drug.
Children under 3 years of age.
From the cardiovascular system: acute period of myocardial infarction, acute and severe chronic heart failure, atherosclerosis, dissecting aortic aneurysm, hypertrophic cardiomyopathy, high-grade arterial hypertension, and low blood pressure.
From the digestive tract: exacerbation of gastric or duodenal ulcer, GERD, decompensated liver failure.
Hormonal disorders: hypothyroidism, thyrotoxicosis.
From the blood system: coagulation disorders and spontaneous bleeding in the anamnesis.
Acute infectious diseases, sepsis.
Severe renal failure.
Epilepsy.

Indications for use of Eufillin

Eufillin - what are these pills for?

Indications for use of Eufillin tablets:

bronchial asthma (BA);
Pickwick's syndrome (paroxysmal sleep apnea);
chronic obstructive bronchitis (COB);
chronic “pulmonary heart”;
emphysema.

Eufillin is the drug of choice for exercise-induced asthma; for other forms of the disease it is used in combination with other drugs.

When is Euphyllin in ampoules prescribed?

Indications for Eufillin in ampoules are:

broncho-obstructive syndrome due to bronchitis , asthma, cardiac asthma (mainly to relieve attacks) or emphysema ;
cerebrovascular insufficiency of the brain (the solution is used in combination with other drugs to reduce intracranial pressure);
hypertension in the pulmonary circulation;
migraine;
left ventricular failure , accompanied by periodic breathing of the Cheyne-Stokes type and bronchospasm (in combination with other drugs).

Pharmacological effects

The main effect of the drug is antispasmodic. However, it also has other effects on the human body, namely tocolytic, diuretic and bronchodilator.

According to the Vidal classifier, Eufillin is included in the pharmacological group of phosphodiesterase inhibitors.

What does Eufillin help with? Indications for use

Indications for use of the drug Eufillin may vary slightly depending on the form of release. Tablets are most often prescribed for:

Bronchial asthma of varying severity.
Chronic obstructive pulmonary disease.
Paroxysmal attacks of apnea at night.
Right ventricular heart failure.
Emphysema.

The injection form of the drug is used for:

Cerebrovascular insufficiency of the brain (the drug is used in combination with other drugs and helps reduce intracranial pressure).
Pulmonary hypertension.
Left ventricular heart failure (also used in combination with a number of other drugs).
For diseases of the respiratory system accompanied by spasm and broncho-obstructive syndrome (COPD, emphysema, bronchial asthma).

Contraindications for Eufillin solution and tablets

Contraindications to the use of tablets:

intolerance to aminophylline or any other xanthine ;
myocardial infarction (MI) in the acute stage;
hypertrophic cardiomyopathy with obstruction;
tachyarrhythmia;
exacerbation of symptoms of stomach/duodenal ulcer ;
severe functional impairment of the kidneys/liver;
epilepsy;
hyperthyroidism.

In pediatrics, it is not prescribed to children under six years of age, or in combination with Phedrine .

Injection of the drug is contraindicated in the following cases:

hypersensitivity to aminophylline and other xanthine ;
MI in the acute stage;
angina pectoris;
OSN;
extrasystoles;
paroxysmal tachycardia;
severe arterial hypotension/hypertension;
pulmonary edema;
vascular atherosclerosis;
hemorrhagic stroke;
there is an indication of any spontaneous bleeding in the anamnesis;
hemorrhage into the retinal tissue;
peptic ulcer in the acute stage;
epilepsy;
increased threshold of convulsive readiness;
gastroesophageal reflux (GER);
uncontrolled hypothyroidism ;
thyrotoxicosis;
hyperthyroidism;
porphyria;
sepsis;
kidney and/or liver dysfunction.

Due to the likelihood of side effects, it is not recommended to use the solution in children under 14 years of age. Children under three years of age are contraindicated to administer Eufillin intravenously; in children over three years of age, the medicine can be used for health reasons and for no more than 14 days.

Euphyllin (Euphyllini)

Ephedrine, beta-agonists, caffeine and furosemide enhance the effect of the drug. Increases the likelihood of developing side effects of glucocorticosteroids, mineralocorticosteroids (hypernatremia), and general anesthesia agents (the risk of ventricular arrhythmias increases). In combination with phenobarbital, phenytoin, rifampicin, isoniazid, carbamazepine or sulfinpyrazone, a decrease in the effectiveness of aminophylline is observed, which may require an increase in the doses of the drug. Aminoglutethimide and moracizine, being inducers of microsomal oxidation, increase the clearance of aminophylline, which may require an increase in its dose.

The clearance of the drug is reduced when prescribed in combination with macrolide antibiotics, lincomycin, allopurinol, cimetidine, isoprenaline, beta-blockers, which may require a dose reduction.

Oral estrogen-containing contraceptives, antidiarrheal drugs, intestinal sorbents weaken, and H2-histamine blockers, slow calcium channel blockers, mexiletine enhance the effect (they bind to the cytochrome P450 enzymatic system and change the metabolism of aminophylline). When used in combination with enoxacin and other fluoroquinolones, small doses of ethanol, disulfiram, recombinant interferon alpha, methotrexate, propafenone, thiabendazole, ticlopidine, verapamil, and when vaccinated against influenza, the intensity of action of aminophylline may increase, which may require a reduction in its dose. The drug suppresses the therapeutic effects of lithium carbonate and beta-blockers. The administration of beta-blockers interferes with the bronchodilatory effect of aminophylline and can cause bronchospasm. Eufillin potentiates the effect of diuretics by increasing glomerular filtration and reducing tubular reabsorption. With caution, aminophylline is prescribed simultaneously with anticoagulants, other theophylline or purine derivatives. It is not recommended to use aminophylline with drugs that excite the central nervous system (increases neurotoxicity). The drug cannot be used with dextrose solutions and is incompatible with fructose and levulose solutions. The pH of the solutions to be mixed must be taken into account: pharmaceutically incompatible with acid solutions.

Side effects

Side effects of using Eufillin tablets:

sleep disturbances, anxiety, dizziness, convulsions, tremor;
irregular heart rhythm, palpitations;
hematuria , albuminuria ;
hypoglycemia (rare).

Against the background of injection therapy, the following are possible:

headache, anxiety, dizziness, agitation, irritability, tremor, insomnia ;
arrhythmias , tachycardia (including in the fetus, if the woman took the drug in the 3rd trimester of pregnancy), palpitations, cardialgia , decreased blood pressure, unstable angina ;
nausea, diarrhea , heartburn, gastralgia , vomiting, exacerbation of symptoms of peptic ulcer , GER, with long-term use - loss of appetite;
itching of the skin, skin rashes, fever;
tachypnea , chest pain, hypoglycemia , albuminuria , increased diuresis, hematuria , increased sweating, feeling of heat in the face.

Side effects are dose-dependent, that is, to relieve them, it is often enough to reduce the dose of the drug.

Local reactions to the injection of the solution manifest themselves in the form of skin hyperemia, pain and the formation of a seal at the injection site.

Instructions for use of Eufillin

Eufillin tablets: instructions for use

The Vidal reference book states that the tablets should be taken orally after meals with plenty of liquid. The dosage of the drug is selected individually, taking into account the different rates of elimination of aminophylline in different patients.

If necessary, the dose is increased every three days until the desired effect is achieved.

Patients weighing more than 50 kg (including teenagers) are prescribed Eufillin for bronchitis and other conditions accompanied by bronchial obstruction at 450-900 mg/day, if necessary, the dose can be increased to 1.2 g with a frequency of use of 4 times ./day with an interval of 6 hours.

For patients weighing less than 50 kg and adolescents whose weight is in the range of 45-55 kg, Eufillin tablets are prescribed to take 450-600 mg/day.

For children 6-17 years old with bronchitis and other broncho-obstructive conditions, tablets are given at the rate of 13 mg/kg, usually 1 tablet 3 times a day.

For COPD in the acute phase, treatment begins with a dose of 5-6 mg/kg (for adults) with further increases. Serum concentration should not exceed 0.02 mg/ml. An increase in the dose for every 0.5 mg/kg leads to an increase in the concentration of the drug in the blood by 0.001 mg/ml.

Outside of an exacerbation, the initial dose of Eufillin for an adult with COPD is 6-8 mg/kg/day, the highest (in the initial stages of treatment) is 400 mg/day. It is recommended to divide it into 3-4 doses.

If used during pregnancy, the dosage (as well as the method of administration) is determined by the doctor. It should be borne in mind that for the mother, an overdose is associated with the risk of cardiac dysfunction (and sometimes cardiac arrest), and for the fetus, high doses of Eufillin are dangerous due to the likelihood of hypoxia and antenatal death.

Eufillin ampoules: instructions for use

For conditions that require emergency care, adult patients are advised to use an infusion with a loading dose of the drug: Eufillin is administered intravenously over half an hour at a dose of 5.6 mg/kg. To prepare a dropper, 10-20 ml of solution is combined with a similar volume of 0.9% aqueous NaCl solution and then the medicine is diluted in 0.25-0.5 liters of physiological solution.

During maintenance therapy, Eufillin is infused into the patient intravenously for 1-3.5 times at a dose of 0.9 mg/kg.

If the patient has previously taken theophylline , the dose of aminophylline should be reduced by at least half.

For status asthmaticus, 720 to 750 mg of aminophylline .

The permissible upper limit of the daily dose for an adult is 0.4-0.5 ml/kg.

Children under 3 months are administered intravenously from 30 to 60 mg of aminophylline per day; for older children and adolescents, the dose varies from 60 to 500 mg/day.

Intravenous injections of Eufillin in emergency conditions are performed for at least five minutes. A single dose for an adult is 6 mg/kg. Before giving the injection, the drug is diluted in 10-20 ml of a 0.9% aqueous solution of NaCl.

The daily dose for intramuscular administration is from 0.1 to 0.5 mg.

For children with COPD, Eufillin is administered at a dose of 5-6 mg/kg (initial dose); during maintenance therapy for children under six months of age, the drug is administered every 8 hours at a dose calculated by the formula: child’s age in weeks * 0.07 + 1, 7.

For children aged six months to one year, the maintenance dose is calculated using the formula: child’s age in weeks * 0.05 + 1.25. The interval between injections is 6 hours.

Children from one to 9 years old are administered 5 mg/kg, children 9-12 years old - 4 mg/kg, children 12-16 years old - 3 mg/kg every 6 hours.

Outside of exacerbation, the initial dose for a child is 16 mg/kg/day, the highest dose is 400 mg/day. It should be divided into 3-4 injections.

If necessary and if Eufillin is well tolerated, the dose is increased every couple of days by 25% to the highest daily dose, which for children under one year old is calculated using the formula “age in weeks * 0.3 +8”, for children under 9 years old it is 22, for children up to 12 years old - 20, for adolescents under 16 years old - 18, for patients over 16 years old - 13 mg/kg.

Eufillin is administered intramuscularly to children at a dose of 15 mg/kg/day. The maximum duration of parenteral use in children is 14 days.

For apnea in children of the first year of life (accompanied by bradycardia and cyanosis , in which the child does not breathe for periods of 15 seconds), the starting dose is 5 mg/kg (the medicine is administered through a nasogastric tube). When carrying out maintenance therapy, the child is recommended to use 2 mg/kg in two doses.

Treatment can last up to several months (usually several weeks).

Electrophoresis with Eufillin

Euphylline for electrophoresis in adults is used to treat arthrosis and osteochondrosis . For electrophoresis, it is prescribed to children for dysplasia , as well as when it is necessary to relieve muscle hypertonicity or reduce intracranial pressure .

In case of cerebrovascular insufficiency or intracranial hypertension , it is performed on the cervical vertebrae; in case of hypertonicity of the child’s legs, it is performed in the lumbar region.

Electrophoresis with Eufillin is a procedure that allows you to create the desired concentration of the active substance directly in the affected tissues. Acting locally, the medicine does not cause systemic side effects, so it can be used in infants older than one month.

The doctor places a gauze cloth soaked in Eufillin solution on the sore spot and secures the electrodes. Exposure time is 15 minutes. This is enough for the drug to penetrate deep into the tissue. The course of treatment is designed for ten sessions.

To restore organ function after birth injuries in newborns, cerebral circulation in pathologies of the cervical spine , as well as in cerebral palsy , electrophoresis according to Ratner is recommended.

The essence of this method is that the patient is placed on two pads impregnated with different drugs: the first (with Eufillin solution 0.5%) - on the cervical vertebrae, the second (with papaverine 1%) - on the ribs, to the right of the sternum. Exposure time is 15 minutes. Current strength is 1-2 mA.

It should be noted that both children and adults tolerate the procedure equally well, so in the absence of contraindications, it can be performed without any fear.

Electrophoresis is contraindicated for any skin diseases, arterial hypertension , arrhythmia , heart failure , or the presence of neoplasms in the patient (any location).

Inhalations with Eufillin for children - effective or inappropriate?

Prescription of Eufillin for children with cough and bronchial obstruction allows them to expand the bronchi, relieve spasm and facilitate the discharge of sputum. However, the drug has these effects only when it enters the systemic circulation.

The use of Eufillin for inhalation belongs to the “off-label” prescribing category. Despite the lack of instructions in the manufacturer's instructions regarding the possibility of using the drug in this way, many people often prescribe this treatment for themselves and, moreover, treat their children in this way.

Most doctors unanimously believe that the effectiveness of inhalations with Eufillin is extremely low, since when inhaling vapors, the drug settles on the mucous membrane and, therefore, does not enter the systemic bloodstream in a therapeutically effective concentration.

The positive effect on the bronchi (their relaxation and improvement of sputum discharge) is due to the fact that during inhalation water vapor enters them. This means that the effectiveness of the drug when used in inhalation is comparable to the effectiveness of ordinary water.

Eufillin for cellulite

One of the properties of aminophylline is the ability to dilate peripheral vessels and restore the functioning of the circulatory system, which in turn cannot. Cellulite, as is known, occurs when blood circulation is impaired and cells begin to suffer from a lack of oxygen. The use of Eufillin allows you to tighten the upper layers of the skin, remove excess fluid and reduce swelling.

For weight loss and getting rid of orange peel, the product is used in the form of creams, masks and wraps. Massage with Eufillin also gives a good effect.

To prepare the composition, the medicine should be mixed with any massage cream, and then add a small amount of Dimexide , which in this case will act as a transporter (thanks to it, aminophylline will be able to penetrate very deeply into the tissues).

For wraps, you can use a mixture of regular baby cream, Dimexide , Euphyllin and tangerine or lemon essential oil (6-8 drops). The composition is applied to the skin cleansed with a scrub and covered with cling film. While it “works” (impact time is usually about 30 minutes), it is recommended to move intensively to enhance the effect.

To prepare anti-cellulite cream based on Eufillin, use the following recipe:

petrolatum;
moisturizing cream;
1 powdered tablet or the contents of 1 ampoule (5 ml) of Eufillin (this dose of the drug is suitable for women weighing less than 75 kg);
Dimexide (for one five-milliliter ampoule of solution, take 2 ml of Dimexide concentrate).

You can also add the drug to a ready-made pharmaceutical anti-cellulite product. The optimal proportion of ingredients is 1:5.

Reviews about Eufillin for cellulite can be found very different - some are completely dissatisfied with the result, others claim that the result exceeded all expectations. Based on this, we can draw the following conclusion - if the remedy works, then definitely not from the first procedure.

Overdose

The annotation states that overdose symptoms develop when the plasma concentration of aminophylline exceeds 0.02 mg/ml. Characteristics are:

diarrhea;
prolonged vomiting;
facial hyperemia;
excitation;
arrhythmia;
tremor;
photophobia;
convulsions.

When the blood concentration exceeds 0.04 mg/ml, the patient falls into a coma.

Helpful measures include stopping the administration of Eufillin to the patient and enhancing natural detoxification by stimulating kidney function (forced diuresis).

If the aminophylline exceeds 0.05 mg/ml, plasmapheresis , hemosorption , peritoneal dialysis or hemodialysis , respiratory support (ventilation and oxygen supply), and monitoring of hemodynamic parameters are indicated.

To relieve convulsive syndrome, the patient is administered diazepam (intramuscularly). The use of barbiturates is contraindicated!

Interaction

The effect of aminophylline is enhanced by use in combination with furosemide , ephedrine, caffeine , and β-adrenergic stimulants .

When used simultaneously with phenytoin , phenobarbital , isoniazid , rifampicin , sulfinpyrazone , carbamazepine of aminophylline is observed , which is accompanied by a decrease in its therapeutic effectiveness and may require an increase in the dose used.

Acceleration of aminophylline is also observed in heavy smokers (at least 20 cigarettes per day).

Use in combination with drugs from the macrolide group, allopurine , isoprenaline , COCs , cimetidine , lincomycin , viloxazine , fluvoxamine , disulfiram , β-blockers , influenza vaccines leads to a slower elimination of aminophylline , an increase in its plasma concentration and, consequently, a reduction in the dose of Euphyllin.

If the drug is prescribed in combination with drugs of the fluoroquinolone group, the dose of Eufillin is reduced to 25% of the usually recommended one.

Aminophylline weakens the therapeutic effect of Li drugs and β-blockers. β-blockers, in turn, weaken the bronchodilator effect of aminophylline .

When taking Eufillin together with corticosteroids (for example, with dexamethasone ), diuretics and β-adrenergic agonists, hypoglycemia increases .

Aminophylline may cause side effects of fluorinated derivatives of general anesthesia ( ventricular arrhythmias ), mineralocorticosteroids (hypernatremia), and drugs that excite the central nervous system ( neurotoxicity ).

May enhance the effect of anticoagulants .

The solution is incompatible with solutions of acids, fructose, glucose and levulose. When preparing for intravenous infusion of an infusion solution, it is necessary to take into account the pH of the solutions used.

Should be used with caution in combination with purine derivatives , theophylline derivatives , and anticoagulants . During the treatment period, it is prohibited to take substances that contain xanthines (including tea and coffee).

In one syringe, Eufillin solution can only be mixed with isotonic NaCl solution.

Eufillin, 24 mg/ml, solution for intravenous administration, 10 ml, 10 pcs.

The clearance of the drug is reduced when prescribed in combination with macrolide antibiotics, lincomycin, allopurinol, cimetidine, isoprenaline, beta-blockers, which may require a dose reduction.

The drug suppresses the therapeutic effects of lithium carbonate and beta-blockers. The administration of beta-blockers interferes with the bronchodilatory effect of aminophylline and can cause bronchospasm. Eufillin potentiates the effect of diuretics by increasing glomerular filtration and reducing tubular reabsorption.

With caution, aminophylline is prescribed simultaneously with anticoagulants, other theophylline or purine derivatives. It is not recommended to use aminophylline with drugs that excite the central nervous system (increases neurotoxicity). The drug cannot be used with dextrose solutions and is incompatible with fructose and levulose solutions. The pH of the solutions to be mixed must be taken into account: pharmaceutically incompatible with acid solutions.

special instructions

The bronchodilator effect of the drug occurs when the concentration of the active substance reaches 0.01-0.02 mg/ml. A concentration exceeding 0.02 mg/ml is toxic.

The stimulating effect on the respiratory center is realized when the content of aminophylline in the blood is in the range from 0.005 to 0.01 mg/ml.

In newborn infants and people over 55 years of age, the medicine is used with caution due to the insufficient activity of the liver enzymatic systems involved in the biotransformation of aminophylline .

In geriatrics, aminophylline should be used in minimal doses while monitoring the plasma concentration of aminophylline .

During the treatment period, you should not eat foods that contain xanthine derivatives: mate, chocolate, coffee, cocoa, strong tea.

The solution is heated to body temperature before administration.

pharmachologic effect

Bronchodilator, methylxanthine derivative; inhibits phosphodiesterase, increases the accumulation of cyclic adenosine monophosphate (cAMP) in tissues, blocks adenosine (purine) receptors; reduces the flow of calcium ions through the channels of cell membranes, reduces the contractile activity of smooth muscles.

Relaxes the bronchial muscles, stimulates the respiratory center and improves alveolar ventilation, which ultimately leads to a reduction in the severity and frequency of apnea episodes.

It has a stimulating effect on the activity of the heart, increases the strength and frequency of heart contractions, increases coronary blood flow and myocardial oxygen demand. Reduces the tone of blood vessels (mainly those of the brain, skin and kidneys). It has a peripheral venodilating effect, reduces pulmonary vascular resistance, and lowers pressure in the pulmonary circulation. Increases renal blood flow and has a moderate diuretic effect. Expands extrahepatic bile ducts.

Stabilizes mast cell membranes, inhibits the release of mediators of allergic reactions.

Inhibits platelet aggregation (suppresses platelet activating factor and prostaglandin E2 alpha), increases the resistance of red blood cells to deformation (improves the rheological properties of blood), reduces thrombus formation and normalizes microcirculation.

It has a tocolytic effect, increases the acidity of gastric juice. When used in large doses, it has an epileptogenic effect.

Analogs

Level 4 ATC code matches:
Aerophyllin

Theotard

Teopek

Theophylline

Aminophylline

Neophylline

Analogs of Eufillin: Aminophyllin-Eskom , Eufillin-pharm , Eufillin-Darnitsa .

Drugs with a similar mechanism of action: Diprophylline , Neo-Teofedrine , Neoteopek A , Teobiolong , Theobromine , Theotard , Teofedrine-N , Theophylline .

Eufillin during pregnancy

The manufacturer, in the instructions for Eufillin, warns that the use of solution/tablets during pregnancy may create concentrations of aminophylline and caffeine that are potentially hazardous to the health of the fetus/newborn.

Children whose mothers received the drug during pregnancy (especially in the third trimester) should be under medical supervision during the neonatal period to monitor possible symptoms of intoxication with methyl xanthine derivatives.

Prescription of Eufillin during pregnancy and lactation is possible only for extreme health reasons and requires an assessment of possible risks for the fetus/child.

Why can Eufillin be prescribed during pregnancy?

Gynecologists recommend the use of Eufillin for edema during pregnancy, for placental insufficiency, in the complex treatment of gestosis , as well as for other conditions that require urgent use of this medicine due to a threat to the life of the mother.

There is no clear treatment regimen for Eufillin during pregnancy, since the manufacturer’s instructions list pregnancy as one of the contraindications for use. The doctor makes all appointments depending on the condition of a particular patient.

Reviews of Eufillin during pregnancy allow us to conclude that the medicine is far from harmless (some women say that after the dropper they felt a strong heartbeat, weakness and dizziness), but for many it helps them to return to normal.

Reviews about Eufillin

The drug is most often used to treat diseases accompanied by airway obstruction , therefore most of the reviews about Eufillin are reviews of its use for bronchitis and asthma .

People who have taken the medicine note that the drug effectively relieves attacks of painful coughing, accelerates the removal of mucus and makes breathing easier. Moreover, improvement occurs literally within 10 minutes after taking the tablet or administering the solution.

During pregnancy (if used correctly in accordance with the doctor's recommendations), the medicine helps to remove excess fluid, normalize the condition and avoid hospitalization in the department of pathology of pregnant women.

There are few negative reviews about the drug and they are primarily associated with individual sensitivity to its active substance.

A separate category of reviews about Eufillin are reviews about the use of tablets and solution for weight loss and against cellulite. For cellulite, the drug is used as an additive to the main anti-cellulite agent, as well as in combination with Dimexide and essential oils.

It is quite difficult to judge the effectiveness of Eufillin against cellulite, since reviews of the results of its use in cosmetology are quite contradictory. Most women claim that it is possible to achieve smooth skin with the help of the drug, but the effect usually becomes noticeable after completing the full course of procedures.

Eufillin price

The price of Eufillin tablets (150 mg No. 30) in Russian pharmacies is 10-12 rubles, a 2.4% solution in 5 ml ampoules (package No. 10) can be bought for 35 rubles, in 10 ml ampoules (package No. 10) - for 40 rubles

In Ukraine, the cost of tablets is from 13 UAH, the price of Eufillin ampoules is from 21 UAH.

Online pharmacies in RussiaRussia
Online pharmacies in UkraineUkraine
Online pharmacies in KazakhstanKazakhstan

ZdravCity

Eufillin solution intravenously.
24mg/ml amp. 5ml 10pcs JSC Dalkhimfarm 52 RUR order
Eufillin solution for intravenous injection. 24 mg/ml 5 ml 10 pcs JSC Novosibkhimpharm
101 rub. order
Eufillin tablets 150 mg 30 pcs. Pharmstandard-Leksredstva OJSC
34 RUR order
Eufillin tablets 0.15g 30pcs PAO Biosintez
37 RUR order

Pharmacy Dialogue

Eufillin (amp. 2.4% 5ml No. 10) DHF JSC
48 RUR order
Eufillin (amp. 2.4% 10ml No. 10)Novosibkhimpharm OJSC
93 RUR order
Eufillin (tab. 150 mg No. 30 (bl.)) Usolye-Sibirsky Chemical Physics Complex
32 RUR order
Eufillin (tab. 150 mg No. 30 (bl.)) Ozon LLC
36 RUR order
Eufillin (tab. 150 mg No. 30 (bl.)) BZMP
20 rub. order

Pharmacy24

Eufillin-pharm 0.4 g No. 30 capsules TOV VTF "Farmakom", Ukraine
23 UAH. order
Eufillin-N 200 2% 5 ml No. 10 solution PAT "Farmak", Ukraine
22 UAH order
Eufillin-Darnitsa 2% 5 ml No. 10 solution
30 UAH order
Eufillin-pharm 0.25 g No. 40 tablets TOV VTF "Farmakom", Ukraine
17 UAH order
Eufillin-pharm 0.25 g No. 80 tablets TOV VTF "Farmakom", Ukraine
31 UAH order

PaniPharmacy

Eufillin ampoule Eufillin 200 solution d/in. 2% amp. 5ml No. 10 Ukraine, Darnitsa ChAO
33 UAH order
Eufillin ampoule Eufillin solution d/in. 2% amp. 5ml No. 10 Ukraine, Health LLC
30 UAH order
Eufillin-pharm tablets 0.25g N40 Ukraine, Farmakom PTF LLC
17 UAH order
Eufillin-pharm tablets 0.25g N80 Ukraine, Farmakom PTF LLC
30 UAH order
Eufillin-pharm capsules 0.4g No. 30 Ukraine, Farmakom PTF LLC
24 UAH order